Background. Although the traditional Chinese medicine Prunella vulgaris may be effective in treating lymphoma, its mechanism of action remains unclear. The purpose of this paper is to explore the mechanism of Prunella vulgaris against lymphoma by combining network pharmacology and molecular docking. Methods. The potential active ingredients of Prunella vulgaris were queried in the TCMSP database. Lymphoma-related genes were searched in the DisgeNet database. After removing the duplicates, the remaining active targets were compared with lymphoma genes to obtain the key target and analyzed using a Venn map. Building a network of protein interactions through String platforms. The GO and KEGG databases were used for enrichment analysis of the key targets with the help of the DAVID analysis platform. Results. A total of 39 potentially active components and 125 targets were identified from Prunella vulgaris, 7592 lymphoma-related target genes, and 101 key target genes for the intersection of Prunella vulgaris and lymphoma. GO entries were related to biological processes including enzyme binding, protein binding, positive regulation of transcription, regulation of cell proliferation, and negative regulation of cell death. KEGG analysis identified the signalling pathways of HIF-1, estrogen, NOD-like receptors, PI3K-Akt, and TNF. The binding between the selected compounds and the target molecules was modelled by molecular docking. Conclusion. Through network pharmacology, it is predicted that Prunella vulgaris may regulate multiple signalling pathways through numerous targets, and thereby affect the functions of multiple cells and playing a role in the treatment of lymphoma.
| Published in | Cancer Research Journal (Volume 9, Issue 3) |
| DOI | 10.11648/j.crj.20210903.14 |
| Page(s) | 154-161 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Prunella Vulgaris, Lymphoma, Network Pharmacology, Molecular Docking
| [1] | Y. Hijikata, J. Kaneko, L. Xi, et al. Traditional Chinese medicines improve the course of refractory leukemic lymphoblastic lymphoma and acute lymphocytic leukemia: two case reports, Am. J. Chin. Med. 23 (2) (1995) 195-211. |
| [2] | H. Wang, F. Wang, S. Wu, Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation, Chem. Biol. Interact. 281 (2018) 11-23. |
| [3] | X. Gu, Y. Li, J. Mu, et al. Chemical constituents of Prunella vulgaris, J. Environ. Sci. (China), 25 (2013) 161-163. |
| [4] | E. H. Han, J. H. Choi, Y. P. Hwang, et al. Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris. Food & Chemical Toxicology, 47 (1) (2009) 62-69. |
| [5] | G. Meng, M. Wang, K. Zhang, et al. Research Progress on the Chemistry and Pharmacology of Prunella vulgaris Species, Oalib. Journal. 2014 (3) (2014) 1-19. |
| [6] | S. Y. Ryu, M. H. Oak, S. K. Yoon, et al. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris, Planta. Med, 66 (4) (2000) 358-360. |
| [7] | Y. Fang, L. Zhang, J. Feng, et al. Spica Prunellae extract suppresses the growth of human colon carcinoma cells by targeting multiple oncogenes via activating miR-34a, Oncol. Rep. 38 (3) (2017) 1895-1901. |
| [8] | D. T. Yin, M. Lei, J. Xu, et al. The Chinese herb Prunella vulgaris promotes apoptosis in human well-differentiated thyroid carcinoma cells via the B-cell lymphoma-2/Bcl-2-associated X protein/caspase-3 signaling pathway, Oncol. Lett. 14 (2) (2017) 1309-1314. |
| [9] | Y. J. HWANG, E. J. LEEi, H. R. KIM, et al. In vitro antioxidant and anticancer effects of solvent fractions from Prunella vulgaris var. lilacina, BMC. Complement. Altern. Med, 13 (1) (2013) 310. |
| [10] | A. L. Hopkins, Network pharmacology, Nature. Biotechnology, 25 (10) (2007) 1110-1111. |
| [11] | Z. H. Liu, X. B. Sun, [Network pharmacology: new opportunity for the modernization of traditional Chinese medicine], Yao. Xue. Xue. Bao, 47 (6) (2012) 696-703. |
| [12] | W. Y. Lee, C. Y. Lee, Y. S. Kim, et al. The Methodological Trends of Traditional Herbal Medicine Employing Network Pharmacology, Biomolecules, 9 (8) (2019) 362. |
| [13] | A. L. Hopkins, Network pharmacology: the next paradigm in drug discovery, Nat. Chem. Biol, 4 (11) (2008) 682-690. |
| [14] | A. Bortolato, M. Fanton, S. J. Mason, et al. Molecular docking methodologies, Methods. Mol. Biol, 34 (2013) 339-360. |
| [15] | F. Bray, J. Ferlay, I. Soerjomataram, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer. J. Clin, 68 (6) (2018) 394-424. |
| [16] | L. A. Torre, F. Bray, R. L. Siegel, et al. Global cancer statistics, 2012, CA. Cancer. J. Clin, 65 (2) (2015) 87-108. |
| [17] | G. G. Kuiper, E. Enmark, M. Pelto-Huikko, et al. Cloning of a novel receptor expressed in rat prostate and ovary, Proc. Natl. Acad. Sci. U. S. A, 93 (12) (1996) 5925-5930. |
| [18] | S. Nilsson, S. Mäkelä, E. Treuter, et al. Mechanisms of estrogen action, Physiol. Rev, 81 (4) (2001) 1535-1565. |
| [19] | K. Yakimchuk, S. M. Hasni, J. Guan, et al. Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists, Blood, 123 (13) (2014) 2054-2061. |
| [20] | V. Nizet, R. S. Johnson, Interdependence of hypoxic and innate immune responses, Nat. Rev. Immunol, 9 (9) (2009) 609-617. |
| [21] | Akhilendra, Kumar, Maurya, et al. Quercetin Regresses Dalton's Lymphoma Growth via Suppression of PI3K/AKT Signaling Leading to Upregulation of p53 and Decrease in Energy Metabolism, Nutr. Cancer, 67 (2) (2015) 354-363. |
| [22] | M. Granato, C. Rizzello, M. S. Montani, Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways, J. Nutr. Biochem, 41 (2017) 124-136. |
| [23] | C. F. Spink, L. J. Keen, F. K. Mensah, et al. Association between non-Hodgkin lymphoma and haplotypes in the TNF region, Br. J. Haematol, 133 (3) (2006) 293-300. |
| [24] | B. Nedoszytko, B. Olszewska, J. Roszkiewicz, et al. The role of polymorphism of interleukin-2, -10, -13 and TNF-α genes in cutaneous T-cell lymphoma pathogenesis, 33 (6) (2016) 429-434. |
| [25] | Y. K. Kim, J. S. Shin, M. H. Nahm, NOD-Like Receptors in Infection, Immunity, and Diseases, Yonsei. Med. J, 57 (1) (2016) 5-14. |
| [26] | L. C. Chiang, W. Chiang, M. Y. Chang, et al. Antileukemic activity of selected natural products in Taiwan, Am. J. Chin. Med, 31 (01) (2003) 37-46. |
| [27] | S. H. Park, S. Ham, T. H. Kwon, et al. Luteolin induces cell cycle arrest and apoptosis through extrinsic and intrinsic signaling pathways in MCF-7 breast cancer cells, J. Environ. Pathol. Toxicol. Oncol, 33 (3) (2014) 219-231. |
| [28] | R. Gharbaran, E. Shang, O. Onwumere, et al. Luteolin Induces Cytotoxicity in Mix Cellularity Classical Hodgkin's Lymphoma via Caspase Activated-cell Death, Anticancer. Res, 40 (9) (2020) 4907-4912. |
| [29] | M. Imran, A. Rauf, ZA. Shah, et al. Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review, Phytother. Res, 33 (2) (2019) 263-275. |
| [30] | C. Liu, F. Gao, B. Li, et al. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21, Leukemia, 25 (9) (2011) 1516-1519. |
| [31] | MK. Kim, C. Suh, HS. Chi, et al. VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma, Cancer. Sci, 103 (3) (2012) 497-503. |
| [32] | P. Salven, A. Orpana, L. Teerenhovi, et al. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients, Blood, 96 (12) (2000) 3712-3718. |
| [33] | M. Blonska, Y. Zhu, H. H. Chuang, et al. Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment, Blood, 125 (6) (2015) 981-991. |
| [34] | F. Bouchard, SD. Bélanger, K. Biron-Pain, et al. EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth, Blood, 116 (5) (2010) 759-766. |
APA Style
Xiaohong Wu, Huiling Song, Aixia Sui, Xinyu Zhao, Hongtao Zhang. (2021). To Explore the Mechanism of Prunella Vulgaris on Lymphoma Based on Network Pharmacology and Molecular Docking. Cancer Research Journal, 9(3), 154-161. https://doi.org/10.11648/j.crj.20210903.14
ACS Style
Xiaohong Wu; Huiling Song; Aixia Sui; Xinyu Zhao; Hongtao Zhang. To Explore the Mechanism of Prunella Vulgaris on Lymphoma Based on Network Pharmacology and Molecular Docking. Cancer Res. J. 2021, 9(3), 154-161. doi: 10.11648/j.crj.20210903.14
AMA Style
Xiaohong Wu, Huiling Song, Aixia Sui, Xinyu Zhao, Hongtao Zhang. To Explore the Mechanism of Prunella Vulgaris on Lymphoma Based on Network Pharmacology and Molecular Docking. Cancer Res J. 2021;9(3):154-161. doi: 10.11648/j.crj.20210903.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.crj.20210903.14,
author = {Xiaohong Wu and Huiling Song and Aixia Sui and Xinyu Zhao and Hongtao Zhang},
title = {To Explore the Mechanism of Prunella Vulgaris on Lymphoma Based on Network Pharmacology and Molecular Docking},
journal = {Cancer Research Journal},
volume = {9},
number = {3},
pages = {154-161},
doi = {10.11648/j.crj.20210903.14},
url = {https://doi.org/10.11648/j.crj.20210903.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20210903.14},
abstract = {Background. Although the traditional Chinese medicine Prunella vulgaris may be effective in treating lymphoma, its mechanism of action remains unclear. The purpose of this paper is to explore the mechanism of Prunella vulgaris against lymphoma by combining network pharmacology and molecular docking. Methods. The potential active ingredients of Prunella vulgaris were queried in the TCMSP database. Lymphoma-related genes were searched in the DisgeNet database. After removing the duplicates, the remaining active targets were compared with lymphoma genes to obtain the key target and analyzed using a Venn map. Building a network of protein interactions through String platforms. The GO and KEGG databases were used for enrichment analysis of the key targets with the help of the DAVID analysis platform. Results. A total of 39 potentially active components and 125 targets were identified from Prunella vulgaris, 7592 lymphoma-related target genes, and 101 key target genes for the intersection of Prunella vulgaris and lymphoma. GO entries were related to biological processes including enzyme binding, protein binding, positive regulation of transcription, regulation of cell proliferation, and negative regulation of cell death. KEGG analysis identified the signalling pathways of HIF-1, estrogen, NOD-like receptors, PI3K-Akt, and TNF. The binding between the selected compounds and the target molecules was modelled by molecular docking. Conclusion. Through network pharmacology, it is predicted that Prunella vulgaris may regulate multiple signalling pathways through numerous targets, and thereby affect the functions of multiple cells and playing a role in the treatment of lymphoma.},
year = {2021}
}
TY - JOUR T1 - To Explore the Mechanism of Prunella Vulgaris on Lymphoma Based on Network Pharmacology and Molecular Docking AU - Xiaohong Wu AU - Huiling Song AU - Aixia Sui AU - Xinyu Zhao AU - Hongtao Zhang Y1 - 2021/07/13 PY - 2021 N1 - https://doi.org/10.11648/j.crj.20210903.14 DO - 10.11648/j.crj.20210903.14 T2 - Cancer Research Journal JF - Cancer Research Journal JO - Cancer Research Journal SP - 154 EP - 161 PB - Science Publishing Group SN - 2330-8214 UR - https://doi.org/10.11648/j.crj.20210903.14 AB - Background. Although the traditional Chinese medicine Prunella vulgaris may be effective in treating lymphoma, its mechanism of action remains unclear. The purpose of this paper is to explore the mechanism of Prunella vulgaris against lymphoma by combining network pharmacology and molecular docking. Methods. The potential active ingredients of Prunella vulgaris were queried in the TCMSP database. Lymphoma-related genes were searched in the DisgeNet database. After removing the duplicates, the remaining active targets were compared with lymphoma genes to obtain the key target and analyzed using a Venn map. Building a network of protein interactions through String platforms. The GO and KEGG databases were used for enrichment analysis of the key targets with the help of the DAVID analysis platform. Results. A total of 39 potentially active components and 125 targets were identified from Prunella vulgaris, 7592 lymphoma-related target genes, and 101 key target genes for the intersection of Prunella vulgaris and lymphoma. GO entries were related to biological processes including enzyme binding, protein binding, positive regulation of transcription, regulation of cell proliferation, and negative regulation of cell death. KEGG analysis identified the signalling pathways of HIF-1, estrogen, NOD-like receptors, PI3K-Akt, and TNF. The binding between the selected compounds and the target molecules was modelled by molecular docking. Conclusion. Through network pharmacology, it is predicted that Prunella vulgaris may regulate multiple signalling pathways through numerous targets, and thereby affect the functions of multiple cells and playing a role in the treatment of lymphoma. VL - 9 IS - 3 ER -
Email: